STERIS plcSTE

時価総額

$259.3億

PER

医療用滅菌・院内消毒サービスの大手。自動内視鏡再処理システムや滅菌装置、器具修理と外部滅菌受託を展開。2023年8月2日のBD資産取得や2024年5月31日の歯科事業売却などM&A実行。事業は米州・欧州・アジア中心に250拠点超で展開。

	2019年 3月31日	2020年 3月31日	2021年 3月31日	2022年 3月31日	2023年 3月31日	2024年 3月31日	2025年 3月31日
Income from continuing operations, net of income tax	305	408	397	243	106	380	616
Depreciation, Depletion and Amortization	226	197	219	553	553	565	476
Deferred income taxes	-7	9	4	-107	-186	-131	-77
Share-based compensation	24	24	26	58	39	57	57
Loss on the disposal of property, plant, equipment, and intangibles, net	-1	0	2	-15	-22	-25	-6
Loss on classification as held for sale	-	-	-	-	-	206	-
Gain (Loss) on Disposition of Business And Equity Investments, Net	-	-	-	-	-	-	-6
Amortization of inventory fair value adjustments	-	-	-	67	7	5	-
Goodwill, Impairment Loss	-	-	-	-	491	-	-
Other items	18	-0	-24	22	25	-12	4
Accounts receivable, net	48	18	-12	52	133	128	29
Inventories, net	15	39	-4	103	124	37	-73
Other current assets	7	-4	-0	-7	24	2	50
Accounts payable	21	-3	-7	15	53	-19	34
Accruals and other, net	59	6	10	-16	-22	40	39
Net cash provided by operating activities	540	591	690	685	757	973	1,148
Purchases of property, plant, equipment, and intangibles, net	190	215	239	288	362	360	370
Proceeds from Sale of Property, Plant, and Equipment	6	4	1	2	15	7	9
Proceeds from Divestiture of Businesses	2	0	1	170	7	9	815
Proceeds from Sale of Other Investments	-	-	-	-	-	4	-
Payments to Acquire Investments	5	-	4	-	-	2	11
Investments in businesses, net of cash acquired	13	110	909	550	43	546	54
Net cash used in investing activities	-213	-320	-1,154	-667	-383	-887	389
Repayments of Secured Debt	-	-	-	345	157	60	638
Payments for Repurchase of Private Placement	-	-	-	-	-	-	80
Proceeds Under Credit Facility, net	-27	-26	-30	-190	242	181	-446
Amortization of Financing Costs	0	1	13	17	-	-	2
Payments of Merger Related Costs, Financing Activities	1	1	2	33	1	6	0
Repurchases of ordinary shares	81	51	15	56	309	12	211
Cash dividends paid to common shareholders	113	123	134	163	183	201	220
Payments to Noncontrolling Interests	-	1	4	1	1	2	2
Proceeds from Noncontrolling Interests	-	6	2	4	-	3	3
Proceeds from (Payments for) Other Financing Activities	-	35	27	10	2	10	25
Net cash (used in) provided by financing activities	-295	-163	346	116	-499	-85	-1,572
Effect of exchange rate changes on cash and cash equivalents	-	-	-	-6	-15	-2	0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	-	99	-99	128	-140	-1	-35